ProVac has developed cost-effectiveness models and other tools to assist countries in making evidence-based decisions on new vaccine introduction.
Models and Tools |
|
ProVac has developed cost-effectiveness models and other tools to assist countries in making evidence-based decisions on new vaccine introduction. |
For information on how to begin an analysis, please visit the ProVac e-Learning Courses.